A Unique Vision of Care. Jefferies 2014 Global Healthcare Conference June 3, 2014
|
|
- Karin Alexander
- 5 years ago
- Views:
Transcription
1 A Unique Vision of Care Jefferies 2014 Global Healthcare Conference June 3, 2014
2 Cautionary Statement The following schedules and statements made in this presentation constitute forward-looking statements contemplated under the Private Securities Litigation Reform Act of These forward-looking statements are based on management s current expectations and are subject to known and unknown uncertainties and risks which could cause actual results to differ materially from those reflected, contemplated or implied by such forward-looking statements including, but not limited to, the following: Termination or non-renewal of contracts by customers Renegotiation of rates paid to and/or by the Company by customers and/or providers Higher utilization of behavioral health treatment services by members Delays, higher costs or inability to implement the Company s initiatives The impact of new or amended laws or regulations Acts of war, terrorism or other catastrophic events The impact of increased competition on ability to maintain or obtain contracts The impact of increased competition on rates paid to or by the Company The impact of share repurchase programs Governmental inquiries and/or litigation Interest rate increases Economic uncertainties Many of these factors are beyond the control of the Company. Any and all forward-looking statements made in this presentation are qualified in their entirety by the complete discussion of risks set forth under the caption Risk Factors in Magellan s Annual Report on Form 10-K for the year ended December 31, 2013 and on subsequent Forms 10-Q. Magellan undertakes no obligation to update any forward-looking or cautionary statements. 2
3 Agenda Magellan Overview Key Strategic Initiatives Magellan Complete Care Magellan Rx Management Financial Highlights 3
4 Magellan: History and Transformation Magellan Today Healthcare Company with a focus on special population management Multi-line Specialty Healthcare Management ( ) Market Leader in Behavioral Health Management (up to 2006) Building on a strong foundation to transform for the future 4
5 Magellan Today - Building for the Future Managed Healthcare Specialty Solutions Pharmacy Management Full Suite of Integrated Specialty Healthcare Products for Targeted Populations Complete Care 5
6 Agenda Magellan Overview Key Strategic Initiatives Magellan Complete Care Magellan Rx Management Financial Highlights 6
7 Magellan Complete Care Strategy Focused on integrated physical and behavioral health management of special populations on a state-specific basis Pursuing on a state-by-state basis through: Partnership Joint Venture Acquisition Internally Developed 7
8 Target Revenue Magellan Complete Care Total medical spend for targeted populations in identified states: >$50B by 2017 Target: Presence in 5-7 states by 2017, managing no less than 5% of the total medical spend, either directly or in partnerships 8
9 Executing on our Magellan Complete Care Strategy Florida MCC of FL (100% owned) -General Medicaid HMO -Awarded contract for a SMI specialty plan Iowa Behavioral Led Health Homes (100% owned) -Comprehensive care coordination for SMI and SED population New York AlphaCare (65% ownership) -Medicaid Managed LTC plan and Medicare plans -Selected to participate in FIDA plan Additional States -Progress on a variety of JV s, partnerships, and wholly-owned capabilities -pursuing HMO licenses in IA, NE, PA, LA 9
10 Magellan Rx Management Capabilities Pharmacy Benefit Management Full service traditional PBM services Pharmacy Benefit Administration Specialty Pharmaceutical Services PBA services for State Medicaid and other government sponsored programs Dispensing operations, contracting and formulary optimization programs Total Drug Management Medical Pharmacy Management Managing the cost and quality of therapeutic interventions for complex conditions covered under the medical benefit 10
11 Magellan Rx Management Strategy Any Drug Pills, tablets, liquids Self-injectables Infused biologics Any Site of Service Self-administered Oral or injectable, purchased via mail order, retail or other location Provider administered Physician office, hospital (IP/OP), home infusion Any Benefit Pharmacy benefit Drugs paid under the medical benefit Combining our deep PBM expertise with industry-leading Medical Pharmacy and Specialty Pharmacy capabilities, we offer a suite of clinical and cost management solutions which provide a comprehensive approach to managing the quality and cost of pharmaceutical care, for any drug, at any provider site of service, under any benefit 11
12 Growing Magellan Rx Management $750.0 $700.0 $712.0 $650.0 $600.0 $578.0 $550.0 $500.0 $450.0 $446.9 $516.4 $400.0 $350.0 $300.0 $324.0 $250.0 $ Revenue Target Magellan Rx Management Revenue: $2.5B by
13 Executing on our Magellan Rx Management Strategy Commercial PBM - Went live 1/1/13 - Expanded public sector PBM capabilities to include commercial capabilities TennCare PBM - Launched 6/1/13 Partners Rx Acquisition - Full-service commercial PBM acquired 10/1/13 CDMI Acquisition -Pharmaceutical rebate and clinical management company acquired 4/30/14 Additional Organic and Inorganic Growth 13
14 Executing on our Magellan Rx Management Strategy CDMI Acquisition -Closed April 30, Base purchase price of $205M ($125M paid in cash & $80M reinvested in restricted common stock) -$65M contingent payment related to 2015 rebate retention targets -$100M potential earn out ($65M related to conversion to full service PBM lives & $35M in related to 2014 & 2015 gross profit targets) Strategic fit: -Offers proven, best-in-class clinical programs & outreach services to help manage chronic conditions -Enhances our rebate management capabilities -Adds customer relationships & ability to cross-sell our PBM capabilities Remainder of 2014 Expected Results -Revenue ~$28M -Segment Profit ~$23M -Stock Compensation Expense ~$20M -Depreciation & Amortization ~$9.5M -Dilutive EPS impact ~$0.14 -Excluding non-cash items, EPS will be accretive by ~$
15 Agenda Magellan Overview Key Strategic Initiatives Magellan Complete Care Magellan Rx Management Financial Highlights 15
16 Financial Highlights Original 2014 Guidance* 2014 Guidance Updated** Revenue $3,207M $3,546M $3.6B - $3.8B $3.6B - $3.8B Cost of Care & COGS $2,400M $2,689M $2.77B - $2.93B Segment Profit $267.4M $259.4M $215M - $235M $238M - $258M Net Income $151.0M $125.3M $57M - $73M $53M - $69M EPS (per diluted common share) $5.42 $4.53 $ $2.56* $ $2.46*** *As of 12/17/13; assumes no further share repurchases. **As of 4/29/14; assumes no further share repurchases and includes CDMI. *** 2014 EPS includes dilutive impact of approx. $0.64 related to amortization of acquisition intangibles & stock comp. exp. for the CDMI acquisition 16
17 Long-term Growth Targets Magellan Complete Care Expansion into new geographies Additional capabilities in other populations Growth in our current states (NY, FL, and IA) Magellan Rx Management Additional scale Capabilities such as Part D and mail order Growing our customer base Growth in Core Behavioral Health and Specialty Solutions Businesses Achieve through Organic and Inorganic Means Long-Term CAGR in both Revenue and EPS of 20% 17
18 Capital Deployment Strategy Invest in Our Businesses Product innovation New capabilities Changing markets and customer needs Disciplined M&A Achieve MCC and Pharmacy Initiatives Consolidation opportunities to strengthen existing businesses and products New capabilities to complement/enhance current products and services From , deployed >$565M of capital for 5 acquisitions Deployed additional capital in 2014 for acquisition of CDMI ($125M) Return Capital to Shareholders Routinely evaluate alternatives Current authorization is $300M and runs through October 2015 $143.2M repurchased through 4/25/2014 on current $300M authorization Returned $893.2M to investors since August 2008 at an average price of $44.21 Magellan has a strong financial position $292M in cash as of 3/31/14 (less $125M for CDMI on 4/30/14), $230M z Credit Facility, and strong cash flow to use for investments in growth and capital deployment 18
19 Strategic Priorities Operational Execution Organic Growth in Existing Businesses Execute on MCC and Pharmacy Initiatives Capital Deployment People Resources 19
20 Q & A
Magellan Health: Innovating for Profitable Growth. Jefferies 2015 Healthcare Conference June 2, 2015
Magellan Health: Innovating for Profitable Growth Jefferies 2015 Healthcare Conference June 2, 2015 Cautionary Statement The schedules and statements made in this presentation include forward-looking statements
More informationMagellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017
Magellan Health Cantor Fitzgerald Healthcare Conference September 26, 2017 Cautionary Statement and Non-GAAP measures 2 This slide presentation and our accompanying oral comments include forward-looking
More informationCIGNA CORPORATION INVESTOR PRESENTATION. May 5, Cigna
CIGNA CORPORATION INVESTOR PRESENTATION May 5, 2017 1 Forward looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
More informationCIGNA CORPORATION. 37 th Annual J.P. Morgan Healthcare Conference January 7, David Cordani President and Chief Executive Officer
CIGNA CORPORATION 37 th Annual J.P. Morgan Healthcare Conference January 7, 2019 David Cordani President and Chief Executive Officer 2 Forward-looking statements and Non-GAAP measures CAUTIONARY STATEMENT
More informationMagellan Health Reports Second Quarter 2018 Financial Results Lowers 2018 Guidance
NEWS RELEASE Media Contact: Lilly Ackley, ackleyl@magellanhealth.com, (860) 507-1923 Investor Contact: Joe Bogdan, jbogdan@magellanhealth.com, (860) 507-1910 Magellan Health Reports Second Quarter 2018
More informationDiplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017
Diplomat s Acquisition of LDI Integrated Pharmacy Services Nov. 15, 2017 1 DISCLAIMERS NON-GAAP INFORMATION We define Adjusted EBITDA as net income (loss) before interest expense, income taxes, depreciation
More informationPharmacy Benefit Managers Overview
Pharmacy Benefit Managers Overview A Presentation to the House Health Innovation Subcommittee Mary Alice Nye, Ph.D. Health and Human Services Staff Director, OPPAGA December 6, 2017 Pharmacy Benefit Managers
More information36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO
36 th Annual J.P. Morgan Healthcare Conference January 9, 2018 Bruce D. Broussard President & CEO 0 Cautionary statement This presentation includes forward-looking statements within the meaning of the
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationJune Investor Presentation
June 2014 Investor Presentation Safe Harbor Certain statements included herein, including guidance and those that express management's objectives and the strategies to achieve those objectives, as well
More informationCIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016 o o o
More informationCIGNA REPORTS STRONG FIRST QUARTER 2018 RESULTS, RAISES OUTLOOK. Shareholders net income for the first quarter was $915 million, or $3.
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG FIRST QUARTER 2018 RESULTS, RAISES OUTLOOK o o o o Total revenues
More informationFourth Quarter 2018 Earnings Conference Call
Fourth Quarter 2018 Earnings Conference Call Larry Merlo President & Chief Executive Officer Eva Boratto Executive Vice President & Chief Financial Officer February 20, 2019 Cautionary Statement Regarding
More informationCONSOLIDATED HIGHLIGHTS. Total Revenues $ 10,318 $ 9,960 $ 10,385 $ 20,703 Net Realized Investment Gains Consolidated Operating
Cigna Reports Strong Second Quarter 2017 Results, Raises Outlook BLOOMFIELD, Conn., 04 August, 2017 - Cigna Corporation (NYSE: CI) today reported second quarter 2017 results with strong performance across
More informationHow ACO s Can Impact Contracting A Real World Example. Mike Medel Pharm D, MBA Banner Health
How ACO s Can Impact Contracting A Real World Example Mike Medel Pharm D, MBA Banner Health Agenda Banner Pharmacy Services Introduction Accountable Care Organization Summary Basic Constructs of ACO Partnership
More informationSanford C. Bernstein Twenty-Second Annual Strategic Decisions Conference 2006
Sanford C. Bernstein Twenty-Second Annual Strategic Decisions Conference 2006 May 31, 2006 Larry C. Glasscock Chairman, President & Chief Executive Officer Safe Harbor Statement Safe Harbor Statement Under
More informationTotal Premium Revenue (GAAP) ($ millions) $4,390.9 $3,578.8 Adjusted Premium Revenue (1) ($ millions) $4,361.4 $3,483.3
WELLCARE REPORTS THIRD QUARTER 2017 RESULTS COMPANY INCREASES FULL-YEAR 2017 GUIDANCE TAMPA, Fla. (Oct. 31, 2017) WellCare Health Plans, Inc. (NYSE: WCG) ( WellCare ) today reported results for the quarter
More informationHealthcare is changing We re changing healthcare. George S. Barrett Chairman and Chief Executive Officer
Healthcare is changing We re changing healthcare. George S. Barrett Chairman and Chief Executive Officer 25th Annual Credit Suisse Healthcare Conference Tuesday, November 8th Copyright 2016, Cardinal Health,
More informationCIGNA REPORTS STRONG SECOND QUARTER 2018 RESULTS, RAISES OUTLOOK. Shareholders net income for the second quarter was $806 million, or $3.
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG SECOND QUARTER 2018 RESULTS, RAISES OUTLOOK o o o Total revenues
More informationExpress Scripts Announces 2018 First Quarter Results
Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 investor.relations@express-scripts.com Express Scripts Announces 2018 First Quarter Results ST. LOUIS,
More informationAkorn, Inc. N a s d a q : A K R X
Akorn, Inc. N a s d a q : A K R X Jefferies 2014 Global Healthcare Conference June 2014 DISCLAIMER This presentation includes certain forward-looking statements regarding our views with respect to our
More informationInnovative Strategies for Managing the Rising Cost of Specialty Drugs
Innovative Strategies for Managing the Rising Cost of Specialty Drugs Mid-sized Retirement and Healthcare Plan Management Conference Chicago, IL June 5, 2013 Managing the Rising Cost of Specialty Drugs
More informationWELLCARE HEALTH PLANS, INC. (Exact name of registrant as specified in its charter)
Section 1: 8-K (8-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report
More information1 sur 10 03/02/ :56
1 sur 10 03/02/2011 13:56 Print Page Close Window Press Release
More informationPERFORMANCE AND TRAJECTORY
PERFORMANCE AND TRAJECTORY José (Joe) E. Almeida Chairman, President and CEO May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results,
More informationCapturing the Opportunity
Capturing the Opportunity JANUARY 2018 BETHANY DIPLOMAT PATIENT Copyright 2018 by Diplomat Pharmacy Inc. Diplomat is a registered trademark of Diplomat Pharmacy Inc. All rights reserved. 1 SPECIALTY DRUGS
More informationJ.P. Morgan 34 th Annual Healthcare Conference -San Francisco- January 11, 2016
J.P. Morgan 34 th Annual Healthcare Conference -San Francisco- January 11, 2016 Forward-Looking Statements During the course of this presentation, we may make projections or other forward-looking statements
More informationWELLCARE REPORTS SECOND QUARTER 2016 RESULTS COMPANY INCREASES FULL-YEAR 2016 GUIDANCE
WELLCARE REPORTS SECOND QUARTER 2016 RESULTS COMPANY INCREASES FULL-YEAR 2016 GUIDANCE TAMPA, Fla. (Aug. 2, 2016) WellCare Health Plans, Inc. (NYSE: WCG) today reported results for the quarter ended 2016.
More informationSelectHealth Prescriptions
SelectHealth Prescriptions pharmacy benefit management program SM SelectHealth Prescriptions is a full-service Pharmacy Benefit Manager (PBM) that offers transparent pricing, clinically based programs,
More informationDelivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer
Delivering Value for All Health Care Stakeholders Larry Merlo President & Chief Executive Officer Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health
More informationOverview of Coverage of Drugs Under the Medicaid Medical Benefit
Overview of Coverage of Drugs Under the Medicaid Medical Benefit June 4, 2008 Amanda Bartelme Avalere Health LLC Avalere Health LLC The intersection of business strategy and public policy Medical vs. Pharmacy
More informationStanding strong for payers and patients
Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE
More informationWest Pharmaceutical Services, Inc. June 2016
West Pharmaceutical Services, Inc. June 2016 Safe harbor statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This slide presentation and any accompanying management
More informationFourth Quarter 2016 Earnings Conference Call
Fourth Quarter 2016 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 9, 2017 Revised 2/9 Forward-looking
More informationInvestor Presentation
Investor Presentation J.P. Morgan 36 th Annual Healthcare Conference San Francisco, CA January 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities
More informationMedicare Congress: Fee for Service Trends: A Look at Medicare Part B
Medicare Congress: Fee for Service Trends: A Look at Medicare Part B November 1, 2005 Lauren Geyer Barnes Avalere Health LLC Avalere Health LLC The intersection of business strategy and public policy Three
More informationCIGNA REPORTS STRONG FIRST QUARTER 2016 RESULTS, RAISES OUTLOOK. Shareholders net income for the first quarter was $519 million, or $2.
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG FIRST QUARTER 2016 RESULTS, RAISES OUTLOOK o o o Consolidated operating
More informationHealthcare is changing We re changing healthcare. George S. Barrett Chairman and Chief Executive Officer
Healthcare is changing We re changing healthcare. George S. Barrett Chairman and Chief Executive Officer 35th Annual J.P. Morgan Healthcare Conference Monday, January 9, 2017 Copyright 2017, Cardinal Health,
More informationPress Release INVESTOR RELATIONS CONTACT: MEDIA CONTACT: Will McDowell 215-761-4198 william.mcdowell2@cigna.com Ellie Polack 860-902-4906 elinor.polack@cigna.com Cigna Delivers Strong 2018 Results as it
More informationJefferies 2017 Global Healthcare Conference Thursday, June 8, 2017
Jefferies 2017 Global Healthcare Conference Thursday, June 8, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of federal securities laws that involve
More informationWILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL
WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL FORWARD LOOKING STATEMENT AND USE OF ADJUSTED MEASURES This presentation contains forward-looking statements including but not limited to
More informationDST SYSTEMS, INC. March 2017
DST SYSTEMS, INC. March 2017 FORWARD LOOKING STATEMENTS Certain material presented in this presentation include forward-looking statements intended to qualify for the safe harbor from liability established
More informationCapturing the Opportunity
Capturing the Opportunity NOVEMBER 2017 BETHANY DIPLOMAT PATIENT Copyright 2017 by Diplomat Pharmacy Inc. Diplomat is a registered trademark of Diplomat Pharmacy Inc. All rights reserved. 1 DISCLAIMERS
More informationExpress Scripts Announces 2017 Fourth Quarter and Full Year Results
Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 investor.relations@express-scripts.com Express Scripts Announces 2017 Fourth Quarter and Full Year
More informationInvestor Presentation. August 2007
Investor Presentation August 2007 Forward-Looking Statement This presentation should be considered forward-looking and is subject to various risk factors and uncertainties. For more information on those
More informationEarnings Presentation 3rd Quarter, 2018
Earnings Presentation 3rd Quarter, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationQ Investor Presentation. May 10, 2017
Q1 2017 Investor Presentation May 10, 2017 Disclaimers FORWARD-LOOKING STATEMENTS. The financial results in this presentation reflect preliminary results, which are not final until our Form 10-K and Form
More informationFOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 10-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December
More informationPharmacy Benefit Managers (PBMs)
Pharmacy Benefit Managers (PBMs) Reducing Costs and Improving Quality Lauren Rowley, VP State Affairs National Conference of State Legislatures May 18, 2018 Overview What is the problem? What is a PBM?
More information2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:
2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),
More informationBlue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific
More informationAmerisourceBergen. CECP CEO Investor Forum Steve Collis, Chairman, President & CEO. February 25, 2019
AmerisourceBergen CECP CEO Investor Forum Steve Collis, Chairman, President & CEO February 25, 2019 Cautionary note regarding forward-looking statements Certain of the statements contained in this presentation
More informationFourth Quarter 2017 Earnings Conference Call
Fourth Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 8, 2018 Important Information No Offer
More informationJP Morgan Healthcare Conference January 13, 2016
JP Morgan Healthcare Conference January 13, 2016 FORWARD-LOOKING STATEMENTS Certain statements and information in this presentation may be deemed to be forward-looking statements within the meaning of
More informationStanding strong for payers and patients
Standing strong for payers and patients Dr. Steve Miller, SVP, Chief Medical Officer Ben Bier, VP Investor Relations W I L L I A M B L A I R 3 7 TH ANNUAL G ROWTH STOCK C ONFERENCE 6.14.17 1 Safe harbor
More information34 th Annual J.P. Morgan Healthcare Conference. Steve Collis, President & CEO Tim Guttman, EVP & CFO
34 th Annual J.P. Morgan Healthcare Conference Steve Collis, President & CEO Tim Guttman, EVP & CFO January 12, 2016 Steve Collis President & CEO Cautionary Note Regarding Forward-Looking Statements Certain
More informationTeva Pharmaceutical Industries Ltd. Fourth Quarter 2018 Results February 13, 2019
Teva Pharmaceutical Industries Ltd. Fourth Quarter 2018 Results February 13, 2019 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning
More informationSurvey Analysis of January 2014 CMS Medicare Part D Proposed Rule
Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule Prepared for: Pharmaceutical Care Management Association Prepared by: Stephen J. Kaczmarek, FSA, MAAA Principal and Consulting Actuary
More informationIncreasing Shareholder Value Wayne DeVeydt EVP & Chief Financial Officer
Increasing Shareholder Value Wayne DeVeydt EVP & Chief Financial Officer Investor Conference February 24, 2009 1 Agenda Earnings Per Share Growth Model And 2009 Outlook WellPoint Remains In A Sound Capital
More informationEarnings Presentation 2nd Quarter 2017
Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
More informationHumana Reports Third Quarter 2017 Financial Results
n e w s r e l e a s e Humana Inc. 500 West Main Street P.O. Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Amy Smith Humana Investor Relations (502) 580 2811 e mail:
More informationMeeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark
Meeting the Health Care Challenges of Tomorrow Jon Roberts Executive Vice President & President, CVS Caremark Agenda PBMs: Needed Now More Than Ever Performance Highlights How We Address Payors #1 Priority:
More informationTEVA REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS. Revenues $18.9 billion $4.6 billion
TEVA REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS FY 2018 Q4 2018 Revenues $18.9 billion $4.6 billion Cash flow from operations $2.4 billion $0.4 billion GAAP loss per share $2.35 $2.85
More informationSteve Liles, PharmD Senior Director, Value Based Purchasing Magellan Medicaid Administration
Medicaid Drug Rebates Steve Liles, PharmD Senior Director, Value Based Purchasing Magellan Medicaid Administration Medicaid Drug Rebates History of Medicaid Drug Rebates and Preferred Drug Lists Affordable
More informationBERNSTEIN. 34 th Annual Strategic Decisions Conference. David Wichmann, CEO May 31, 2018
BERNSTEIN 34 th Annual Strategic Decisions Conference David Wichmann, CEO May 31, 2018 2018 UnitedHealth Group. All Rights Reserved. UnitedHealth Group is a registered trademark with the U.S. Patent and
More informationMedicaid Program; Covered Outpatient Drugs; Proposed Rule (CMS-2345-P) NHIA Summary
Medicaid Program; Covered Outpatient Drugs; Proposed Rule (CMS-2345-P) NHIA Summary The Centers for Medicare & Medicaid Services (CMS) on February 2, 2012 published in the Federal Register a proposed rule
More informationFEEL BETTER. CONNECTED.
FEEL BETTER. CONNECTED. Connected across pharmacy and medical. To take you further. Katy Wong, RPh, MBA Vice President, Producer Relations Cigna Pharmacy Management Offered by: Cigna Health and Life Insurance
More informationJP Morgan 27th Annual Healthcare Conference Angela F. Braly President & Chief Executive Officer January 12, 2009
JP Morgan 27th Annual Healthcare Conference Angela F. Braly President & Chief Executive Officer January 12, 2009 Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995 The statements
More informationUnderstanding Your Prescription Program. CCIU Employee Meeting September 7, 2016
Understanding Your Prescription Program CCIU Employee Meeting September 7, 2016 Welcome to FutureScripts! Founded in 2006 Philadelphia presence Strong ties to community and local businesses 68,000 pharmacies
More informationWELLCARE REPORTS FIRST QUARTER 2016 RESULTS
WELLCARE REPORTS FIRST QUARTER 2016 RESULTS COMPANY INCREASES FULL-YEAR 2016 GUIDANCE TAMPA, Fla. (May 3, 2016) WellCare Health Plans, Inc. (NYSE: WCG) today reported results for the quarter ended March
More information(401) (212) FOR IMMEDIATE RELEASE CVS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS AND PROVIDES 2019 FULL YEAR GUIDANCE
Investor Mike McGuire Media T.J. Crawford Contact: Senior Vice President Contact: Vice President Investor Relations External Affairs (401) 770-4050 (212) 457-0583 FOR IMMEDIATE RELEASE CVS HEALTH REPORTS
More informationCVS CAREMARK REPORTS RECORD SECOND QUARTER REVENUES, OPERATING PROFIT, AND EARNINGS
Investor Contact: Nancy Christal Media Contact: Eileen Howard Dunn Senior Vice President Senior Vice President Investor Relations Corporate Communications & (914) 722-4704 Community Relations (401) 770-4561
More informationRisk Contracting: What to Know About Stop Loss Insurance KATHRYN A BOWEN, EXECUTIVE VICE-PRESIDENT OCTOBER 27, 2016
Risk Contracting: What to Know About Stop Loss Insurance KATHRYN A BOWEN, EXECUTIVE VICE-PRESIDENT OCTOBER 27, 2016 Provider Stop Loss Insurance Premiums Program Structure Losses within Retention What
More informationRe: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]
January 25, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing
More informationImplementing the Medicare Drug Benefit. Robert Donnelly Director, Medicare Drug Benefit Group June 8, 2005
Implementing the Medicare Drug Benefit Robert Donnelly Director, Medicare Drug Benefit Group June 8, 2005 Medicare Challenges Providing the best care for a Medicare population that has longer life expectancy
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationWalgreens Boots Alliance Fiscal year end 2015 and 4Q earnings conference call. 28 October 2015
Walgreens Boots Alliance Fiscal year end 2015 and 4Q earnings conference call 28 October 2015 Fiscal year end 2015 and 4Q earnings call agenda Topic Introduction & Safe Harbor Business Overview Financial
More informationEmpire BlueCross Lab, DME, and Specialty Pharmacy Blue Claims
Medicare Advantage Provider s Frequently Asked Questions Empire BlueCross Lab, DME, and Specialty Pharmacy Blue Claims Generally, as a healthcare provider you should file claims for your Blue Cross and
More informationOverview of the BCBSRI Prescription Management Program
Overview of the BCBSRI Prescription Management Program A. Prescription Drugs Dispensed at a Pharmacy This plan covers prescription drugs listed on the Blue Cross & Blue Shield RI (BCBSRI) formulary and
More informationCIGNA REPORTS FIRST QUARTER 2012 RESULTS Raises Outlook for 2012 Earnings and Customer Growth
NEWS RELEASE Contact: Ted Detrick, Investor Relations (215) 761-1414 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS FIRST QUARTER 2012 RESULTS Raises Outlook for 2012 Earnings and Customer
More informationCardinal Health Reports Second-quarter Results for Fiscal Year 2018
FOR IMMEDIATE RELEASE Media: Ellen Barry Investors: Lisa Capodici (614) 553-3858 (614) 757-5035 ellen.barry@cardinalhealth.com lisa.capodici@cardinalhealth.com Cardinal Health Reports Second-quarter Results
More informationI. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
More informationLehman Brothers 2007 Global Healthcare Conference March 20, Ronald A. Williams Chairman, CEO and President
March 20, 2007 Ronald A. Williams Chairman, CEO and President 2 Cautionary Statement CAUTIONARY STATEMENT -- Certain information in this presentation is forward looking information. Forward-looking information
More informationSecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals
SecurityBlue HMO Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality
More informationLHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017
LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare November 16, 2017 Forward-Looking Statements This presentation contains forward looking statements (as defined in the Securities
More informationKEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)
The Texas Association of Health Plans Representing health insurers, health maintenance organizations, and other related health care entities operating in Texas. KEEPING PRESCRIPTION DRUGS AFFORDABLE: The
More informationDST SYSTEMS, INC. November 2017
DST SYSTEMS, INC. November 2017 FORWARD LOOKING STATEMENTS Certain material presented in this presentation include forward-looking statements intended to qualify for the safe harbor from liability established
More informationThe U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD
The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use Presented by Daniel Tomaszewski Pharmd, PhD 1 Medical Vs. Pharmacy Coverage Medical Insurance Managed by an Insurance
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December
More informationQ INVESTOR PRESENTATION. May 4, 2018
Q 208 INVESTOR PRESENTATION May 4, 208 DISCLAIMERS FORWARD-LOOKING STATEMENTS. The financial results in this presentation reflect preliminary unaudited results, which are not final until Form 0-Q for the
More informationLeading humanity to healthy, vibrant lives Annual Report
Leading humanity to healthy, vibrant lives 2017 Annual Report Strengthening Our Position To Our Shareholders, Customers and Members: As we look back over the last year, we have made major strides towards
More informationTeva Pharmaceutical Industries Ltd. Q August 2, 2018
Teva Pharmaceutical Industries Ltd. Q2 2018 August 2, 2018 Cautionary Note Regarding Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of the Private
More informationCigna Corporation Quarterly Financial Supplement December 31, 2014
Quarterly Financial Supplement December 31, 2014 This document is dated February 5, 2015. The data contained in this document may not be accurate after such date and Cigna does not undertake to update
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationLHC GROUP AND ALMOST FAMILY ANNOUNCE MERGER OF EQUALS TO CREATE LEADING NATIONAL PROVIDER OF IN-HOME HEALTHCARE SERVICES
LHC GROUP AND ALMOST FAMILY ANNOUNCE MERGER OF EQUALS TO CREATE LEADING NATIONAL PROVIDER OF IN-HOME HEALTHCARE SERVICES National platform enables greater service and continuity across continuum of care
More information2016 Benefits Overview
2016 Benefits Overview ASPIRE HEALTH ADVANTAGE VALUE (HMO) BENEFIT Monthly Plan Premium Out-of-Pocket Limit (In-Network Medicare-covered benefits) Annual Part C Deductible (all services except for Prescription
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationHealthcare Purchasing in an Era of Accountable Care: How Will Provider Groups Define and Deliver Value?? What will it take?
Healthcare Purchasing in an Era of Accountable Care: How Will Provider Groups Define and Deliver Value?? What will it take? P sharon.levine@kp.org The Permanente Medical Group June 2013 Copyright 2013
More informationThird Quarter 2017 Earnings Conference Call
Third Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 6, 2017 Forward-looking Statements This
More information